Inflazome's Grant

Inflazome raised a round of funding on March 25, 2019. Investors include Michael J. Fox Foundation for Parkinson's Research.

Inflazome develops orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome, which drives many chronic inflammatory conditions.…

Articles about Inflazome's Grant: